Stanford Root

Schedule

Stanford Root

Schedule

BIOS 219

Early Development Strategies for Neutralizing Antibodies and Brain Permeable Small Molecules

UNITS:1
GRADING:Medical Satisfactory/No Credit
LEVEL:Graduate
GER:—

This course will provide students with an overview of current technologies related to the development of small molecules and neutralizing antibodies. Delivered via classroom instruction and a workshop, these modules will aim to increase the fundamental understanding of drug development terminology and processes, combined with real-world examples of discovery therapeutics and technologies developed for translation to clinic. Emphasis will be made on the development of small molecules that can cross the blood-brain barrier and show potential for translation in clinic. Focus will also be put on the screening of antibody targets followed by target validation, target profile development and preclinical evaluation. The workshop will focus on computational molecular docking which is an excellent tool that will help reduce the attrition rate during the drug development process and lead identification studies. Active engagement of the students during the workshop is expected based on the need to install specific software and completion of assigned tasks (computational docking). Students are expected to bring personal laptops to class on day 1 and 2 to perform docking exercises.

Syllabus for selected term:
View Winter 2027 Syllabus

Sections

1 Term
Lecture 1Open
ID: 26594
0 / 999 enrolled
DAYS:TBD
TIME:TBD
LOCATION:TBD
1unit
Lab Section 1Open
ID: 26593
0 / 999 enrolled
DAYS:TBD
TIME:TBD
LOCATION:TBD
1unit

BIOS 219: Early Development Strategies for Neutralizing Antibodies and Brain Permeable Small Molecules

1 units · Medical Satisfactory/No Credit

This course will provide students with an overview of current technologies related to the development of small molecules and neutralizing antibodies. Delivered via classroom instruction and a workshop, these modules will aim to increase the fundamental understanding of drug development terminology and processes, combined with real-world examples of discovery therapeutics and technologies developed for translation to clinic. Emphasis will be made on the development of small molecules that can cross the blood-brain barrier and show potential for translation in clinic. Focus will also be put on the screening of antibody targets followed by target validation, target profile development and preclinical evaluation. The workshop will focus on computational molecular docking which is an excellent tool that will help reduce the attrition rate during the drug development process and lead identification studies. Active engagement of the students during the workshop is expected based on the need to install specific software and completion of assigned tasks (computational docking). Students are expected to bring personal laptops to class on day 1 and 2 to perform docking exercises.

Offered in Winter 2027 at Stanford University.

Winter 2027 sections

  • Lab Section — TBA TBA (Graduate)
  • Lecture — TBA TBA (Graduate)

More BIOS courses

  • BIOS 209: Experimental Design and Tools for Human Electrophysiology
  • BIOS 214: Open-Source MRI Sequence Development: Simulation to Scanner
  • BIOS 215: Stanford SKY Campus Happiness Retreat
  • BIOS 216: The Practice of Reproducible Research
  • BIOS 217: Foundations of statistics and reproducible research
  • BIOS 218: The Evolution of Evolvability
  • BIOS 223: Development and reporting of robust and reproducible LC-MS/MS assays
  • BIOS 224: Stem Cell Biology and Applications
  • BIOS 225: Diversity and Inclusion in STEMM
  • BIOS 226: Web3, AI, and Digital Health
  • BIOS 227: Mass Spectrometry and Proteomics: Opening the Black Box
  • BIOS 229: Open Source Prototyping: Translating Ideas to Reality using Rapid Prototyping Methods

All BIOS courses · All departments